Autor(es):
Fonseca-Gomes, João ; Loureiro, Joana A ; Tanqueiro, Sara ; Mouro, Francisco ; Ruivo, Pedro ; Carvalho, Tânia ; Sebastião, Ana M ; Diógenes, Maria José ; Pereira, Maria Carmo
Data: 2020
Identificador Persistente: http://hdl.handle.net/10451/47280
Origem: Repositório da Universidade de Lisboa
Assunto(s): PLGA nanoparticles; Drug delivery systems; Liposomes; Long-lasting treatment; Nanocarriers; Solid lipid nanoparticles
Descrição
Nanoparticles (NPs), as drug delivery systems, appear to be a promising tool for prolonged therapeutic strategies as they allow a controlled drug release over time. However, most of the studies found in the literature simply contemplate the use of a single or low number of dosages with low NPs concentrations. In the context of chronic diseases, like Alzheimer's disease, cancer or human immunodeficiency virus (HIV), where the therapeutic scheme is also chronic, studies with numerous repeated dosages are often neglected.